Co-Authors
This is a "connection" page, showing publications co-authored by John Laffey and Dave Singh.
Connection Strength
0.114
-
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. Br J Clin Pharmacol. 2021 08; 87(8):3075-3091.
Score: 0.058
-
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care. 2020 07 22; 24(1):454.
Score: 0.056